Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma

Saurabh Singhal, Harit Kapoor, Saravanan Subramanian, Devendra K. Agrawal, Sumeet K. Mittal

Research output: Contribution to journalArticle

Abstract

Purpose: The vitamin D receptor (VDR) endocrine system has emerged as an endogenous pleiotropic biological cell regulator with anti-neoplastic effects on breast, colorectal, and prostatic adenocarcinomas. We studied the association of gene expression, polymorphisms of VDR, CYP27B1, and CYP24A1 genes and serum vitamin D levels as surrogate markers of disease progression in patients with acid reflux, Barrett’s esophagus (BE), or esophageal adenocarcinoma (EAC). Methods: We analyzed blood and tissue samples from patients with biopsy-confirmed BE or EAC for vitamin D levels, gene expressions, and polymorphisms in VDR (FokI [F/f], BsmI [B/b], ApaI [A/a], and TaqI [T/t]), CYP27B1 (HinfI [H/h]), and CYP24A1 (Hpy1881 [Y/y]). Percentages of homozygous dominant/recessive or heterozygous traits were assessed for each polymorphism in all patient subgroups. Results: Genomic Bb and FF polymorphisms were highly prevalent in EAC patients, whereas BE patients had a high prevalence of wild-type Hpy1881 (YY polymorphism). Some polymorphisms (Yy for CYP24A1, bb for VDR) were noted only in EAC patients. Yy and bb forms were both uniquely present in some EAC patients without associated Barrett’s lesions, but not in patients with concomitant BE. AA and bb polymorphisms were associated with decreased response to neoadjuvant therapy. A high level of VDR and CYP24A1 mRNA expression was observed in EAC tissue of non-responders. Serum vitamin D deficiency was common in EAC patients. Conclusions: Specific polymorphisms in vitamin D metabolism-related genes are associated with the likelihood of reflux–BE–EAC progression. Identifying such polymorphisms may aid in development of better surveillance and diagnostic and therapeutic protocols.

Original languageEnglish (US)
JournalJournal of Gastrointestinal Cancer
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Vitamin D
Adenocarcinoma
Calcitriol Receptors
Barrett Esophagus
Genes
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
Gene Expression
Endocrine System
Neoadjuvant Therapy
Vitamin D Deficiency
Serum
Disease Progression
Breast
Biomarkers
Biopsy
Messenger RNA
Acids
Vitamin D3 24-Hydroxylase

All Science Journal Classification (ASJC) codes

  • Oncology
  • Gastroenterology

Cite this

Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma. / Singhal, Saurabh; Kapoor, Harit; Subramanian, Saravanan; Agrawal, Devendra K.; Mittal, Sumeet K.

In: Journal of Gastrointestinal Cancer, 01.01.2018.

Research output: Contribution to journalArticle

@article{a845758122eb4efba12462fba06796c0,
title = "Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma",
abstract = "Purpose: The vitamin D receptor (VDR) endocrine system has emerged as an endogenous pleiotropic biological cell regulator with anti-neoplastic effects on breast, colorectal, and prostatic adenocarcinomas. We studied the association of gene expression, polymorphisms of VDR, CYP27B1, and CYP24A1 genes and serum vitamin D levels as surrogate markers of disease progression in patients with acid reflux, Barrett’s esophagus (BE), or esophageal adenocarcinoma (EAC). Methods: We analyzed blood and tissue samples from patients with biopsy-confirmed BE or EAC for vitamin D levels, gene expressions, and polymorphisms in VDR (FokI [F/f], BsmI [B/b], ApaI [A/a], and TaqI [T/t]), CYP27B1 (HinfI [H/h]), and CYP24A1 (Hpy1881 [Y/y]). Percentages of homozygous dominant/recessive or heterozygous traits were assessed for each polymorphism in all patient subgroups. Results: Genomic Bb and FF polymorphisms were highly prevalent in EAC patients, whereas BE patients had a high prevalence of wild-type Hpy1881 (YY polymorphism). Some polymorphisms (Yy for CYP24A1, bb for VDR) were noted only in EAC patients. Yy and bb forms were both uniquely present in some EAC patients without associated Barrett’s lesions, but not in patients with concomitant BE. AA and bb polymorphisms were associated with decreased response to neoadjuvant therapy. A high level of VDR and CYP24A1 mRNA expression was observed in EAC tissue of non-responders. Serum vitamin D deficiency was common in EAC patients. Conclusions: Specific polymorphisms in vitamin D metabolism-related genes are associated with the likelihood of reflux–BE–EAC progression. Identifying such polymorphisms may aid in development of better surveillance and diagnostic and therapeutic protocols.",
author = "Saurabh Singhal and Harit Kapoor and Saravanan Subramanian and Agrawal, {Devendra K.} and Mittal, {Sumeet K.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s12029-018-0164-6",
language = "English (US)",
journal = "Journal of Gastrointestinal Cancer",
issn = "1941-6628",
publisher = "Humana Press",

}

TY - JOUR

T1 - Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma

AU - Singhal, Saurabh

AU - Kapoor, Harit

AU - Subramanian, Saravanan

AU - Agrawal, Devendra K.

AU - Mittal, Sumeet K.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: The vitamin D receptor (VDR) endocrine system has emerged as an endogenous pleiotropic biological cell regulator with anti-neoplastic effects on breast, colorectal, and prostatic adenocarcinomas. We studied the association of gene expression, polymorphisms of VDR, CYP27B1, and CYP24A1 genes and serum vitamin D levels as surrogate markers of disease progression in patients with acid reflux, Barrett’s esophagus (BE), or esophageal adenocarcinoma (EAC). Methods: We analyzed blood and tissue samples from patients with biopsy-confirmed BE or EAC for vitamin D levels, gene expressions, and polymorphisms in VDR (FokI [F/f], BsmI [B/b], ApaI [A/a], and TaqI [T/t]), CYP27B1 (HinfI [H/h]), and CYP24A1 (Hpy1881 [Y/y]). Percentages of homozygous dominant/recessive or heterozygous traits were assessed for each polymorphism in all patient subgroups. Results: Genomic Bb and FF polymorphisms were highly prevalent in EAC patients, whereas BE patients had a high prevalence of wild-type Hpy1881 (YY polymorphism). Some polymorphisms (Yy for CYP24A1, bb for VDR) were noted only in EAC patients. Yy and bb forms were both uniquely present in some EAC patients without associated Barrett’s lesions, but not in patients with concomitant BE. AA and bb polymorphisms were associated with decreased response to neoadjuvant therapy. A high level of VDR and CYP24A1 mRNA expression was observed in EAC tissue of non-responders. Serum vitamin D deficiency was common in EAC patients. Conclusions: Specific polymorphisms in vitamin D metabolism-related genes are associated with the likelihood of reflux–BE–EAC progression. Identifying such polymorphisms may aid in development of better surveillance and diagnostic and therapeutic protocols.

AB - Purpose: The vitamin D receptor (VDR) endocrine system has emerged as an endogenous pleiotropic biological cell regulator with anti-neoplastic effects on breast, colorectal, and prostatic adenocarcinomas. We studied the association of gene expression, polymorphisms of VDR, CYP27B1, and CYP24A1 genes and serum vitamin D levels as surrogate markers of disease progression in patients with acid reflux, Barrett’s esophagus (BE), or esophageal adenocarcinoma (EAC). Methods: We analyzed blood and tissue samples from patients with biopsy-confirmed BE or EAC for vitamin D levels, gene expressions, and polymorphisms in VDR (FokI [F/f], BsmI [B/b], ApaI [A/a], and TaqI [T/t]), CYP27B1 (HinfI [H/h]), and CYP24A1 (Hpy1881 [Y/y]). Percentages of homozygous dominant/recessive or heterozygous traits were assessed for each polymorphism in all patient subgroups. Results: Genomic Bb and FF polymorphisms were highly prevalent in EAC patients, whereas BE patients had a high prevalence of wild-type Hpy1881 (YY polymorphism). Some polymorphisms (Yy for CYP24A1, bb for VDR) were noted only in EAC patients. Yy and bb forms were both uniquely present in some EAC patients without associated Barrett’s lesions, but not in patients with concomitant BE. AA and bb polymorphisms were associated with decreased response to neoadjuvant therapy. A high level of VDR and CYP24A1 mRNA expression was observed in EAC tissue of non-responders. Serum vitamin D deficiency was common in EAC patients. Conclusions: Specific polymorphisms in vitamin D metabolism-related genes are associated with the likelihood of reflux–BE–EAC progression. Identifying such polymorphisms may aid in development of better surveillance and diagnostic and therapeutic protocols.

UR - http://www.scopus.com/inward/record.url?scp=85052946525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052946525&partnerID=8YFLogxK

U2 - 10.1007/s12029-018-0164-6

DO - 10.1007/s12029-018-0164-6

M3 - Article

JO - Journal of Gastrointestinal Cancer

JF - Journal of Gastrointestinal Cancer

SN - 1941-6628

ER -